Determination of the susceptibility of Mycobacterium tuberculosis to pyrazinamide in liquid and solid media assessed by a colorimetric nitrate reductase assay

The Journal of Antimicrobial Chemotherapy
H SyreH M S Grewal

Abstract

The aim of this study was to develop and evaluate two colorimetric nitrate reductase-based antibiotic susceptibility (CONRAS) tests, the CONRAS-liquid test and the CONRAS-LJ test, to enable susceptibility testing of Mycobacterium tuberculosis to pyrazinamide. To enhance the growth of M. tuberculosis in 7H9 broth with acid pH (6.0), the effect of three potential growth-promoting substances (reconstitution fluid, fastidious organism supplement and epidermal growth factor) was evaluated. Seventy-five M. tuberculosis strains were tested for susceptibility to pyrazinamide in the CONRAS-liquid test performed in Middlebrook 7H9 broth, and 77 M. tuberculosis strains were tested for susceptibility to pyrazinamide in the CONRAS-LJ test performed on Löwenstein-Jensen medium. The BACTEC 460TB system, sequencing of the pncA gene and Wayne's assay were used as reference tests. Growth of 10 M. tuberculosis strains in conventional 7H9 broth and in acid 7H9 broth with and without growth-promoting substances added was evaluated by the nitrate reductase assay. By using the BACTEC 460TB system as the reference test, the sensitivity and specificity of the CONRAS-liquid test (100 mg/L pyrazinamide) tested on 75 M. tuberculosis strains were 87.5% and...Continue Reading

References

Jul 1, 1988·Antimicrobial Agents and Chemotherapy·M Salfinger, L B Heifets
Dec 1, 1982·Journal of Clinical Microbiology·W R Butler, J O Kilburn
Mar 1, 1997·Antimicrobial Agents and Chemotherapy·A ScorpioY Zhang
Mar 1, 1997·Antimicrobial Agents and Chemotherapy·S SreevatsanJ M Musser
Apr 4, 2000·Journal of Clinical Microbiology·L Heifets, T Sanchez
Feb 5, 2002·Journal of Clinical Microbiology·K A Kristian AngebySven E Hoffner
May 1, 2002·Journal of Clinical Microbiology·Gaby E PfyfferSabine Rüsch-Gerdes
Nov 6, 2007·The Journal of Antimicrobial Chemotherapy·Anandi MartinJuan Carlos Palomino
Aug 30, 2008·Journal of Clinical Microbiology·Matsie MphahleleHarleen M S Grewal

❮ Previous
Next ❯

Citations

Mar 10, 2015·Expert Review of Anti-infective Therapy·Matthias StehrMahavir Singh
Jun 3, 2021·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Sirus AminiMohammad Mehdi Feizabadi
Sep 29, 2021·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Mohammad BagheriMohammad Javad Nasiri

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.